drugset / Trial / NCT04822415

Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine With Symptomatic Irreversible Pulpitis

NCT04822415

Completed 330 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this randomized, double-blinded, clinical trial was to assess the effect of 3.6 mL 2% mepivacaine hydrochloride with 1:100,000 epinephrine compared to 3.4 mL 4% articaine hydrochloride with 1:100,000 epinephrine on the success of the inferior alveolar nerve block for patients with symptomatic irreversible pulpitis in mandibular molars.

Timeline

Start
2014-12
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Articaine Other / unclassified 3.4 ml Other
Comparator Articaine Other / unclassified 4 % Other
Subject Mepivacaine Other / unclassified 2 % Other
Subject Mepivacaine Other / unclassified 3.6 ml Other
Background Epinephrine Other / unclassified Other

Indications